Uman Pharma Inc., a Canadian privately owned generic pharmaceutical company is pleased to announce the conclusion of a strategic partnership with CFR Pharmaceuticals S. A. (CFR) of Santiago, Chile.

Under the terms of the agreement, Antares and Uman will invest jointly to develop and commercialize VIBEX^TM MTX, Antares' novel pressure-assisted injection device, containing methotrexate for rheumatoid arthritis and related autoimmune conditions in the US and Canada.

Uman Pharma is proud to announce the receipt of the Establishment Licence from Health Canada for the production and packaging of sterile and solid oral dosage pharmaceutical products.

Uman Pharma is offering the newly generic EPIRUBICIN drug in Canada.

Uman Pharma is proud to announce the acquisition of the Bristol Myers-Squibb facility in Candiac (Canada).